Please use this identifier to cite or link to this item:
Title: The mRNA-based coronavirus disease-2019 vaccine-induced severe cardiomyopathy: A rare incident.
Author: Jamil, Afshan
Cullinane, Ross
Agahi, Afshin
Paymard, Mohammad
Issue Date: 2022
Publication Title: Heart Views
Volume: 23
Issue: 3
Start Page: 187
End Page: 189
Abstract: We are presenting a case of severe dilated cardiomyopathy (DCM) post-mRNA-based coronavirus disease-2019 (COVID-19) vaccine (Pfizer-BioNTech) in a young healthy man. After the second dose of the vaccine, his health rapidly declined, and he developed severe DCM with reduced ejection fraction. Investigations for other causes of DCM were unremarkable. Severe DCM following COVID-19 vaccine injection is a rare but serious condition. It also highlights the importance of close follow-up of pericarditis and perimyocarditis cases post-COVID-19 vaccine and we recommend clinicians have a low threshold for using echocardiography for early diagnosis and management.
Internal ID Number: 02052
Health Subject: VACCINATION
Type: Journal Article
Appears in Collections:Research Output

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.